NorthEdge Completes Multi‑Million‑Pound Investment into Antibody Analytics

NorthEdge Invests in Torbay Pharmaceuticals

November 20, 2023

Pharmaceuticals

NorthEdge has acquired Torbay Pharmaceuticals, a UK-based sterile injectable contract manufacturer, from Torbay and Devon NHS Foundation Trust to support the company's next phase of international growth. The investment (funded by NorthEdge Fund III) will back expansion into North America, strengthen fill/finish and plastic vial capabilities, increase automation, and support growth of Torbay's c.250-strong team at its Paignton, Devon HQ.

NorthEdge Invests in ramarketing

April 20, 2022

Marketing & Advertising

NorthEdge has completed a growth investment in ramarketing, a life-sciences-focused full-service marketing agency, to support international expansion and service capability growth. The backing will help ramarketing expand its US footprint, enhance its creative, content and digital offerings, and continue hiring across its Newcastle, Manchester and Boston offices.

Rockland Immunochemicals Acquires antibodies-online GmbH with financing from BroadOak Capital

February 10, 2022

Biotechnology

Rockland Immunochemicals, a Pennsylvania-based life sciences tools manufacturer, has acquired antibodies-online GmbH, a Germany-based e-commerce marketplace for antibodies and research reagents. BroadOak Capital Partners provided financing to support the transaction, which combines Rockland’s antibody design and manufacturing capabilities with antibodies-online’s e-commerce platform and supplier network to expand capabilities, scale distribution, and strengthen supply-chain stability for research customers worldwide.

Biosynth Acquires Cambridge Research Biochemicals (CRB)

May 9, 2023

Biotechnology

Biosynth, a Switzerland-based supplier of critical materials to the life science industry, has acquired Cambridge Research Biochemicals (CRB), a UK-based independent producer of custom peptides and antibody tools. The acquisition expands Biosynth's peptide and antibody capabilities in Europe, adding expertise in complex peptide chemistry, fluorescent dye labelling and custom antibody generation to its existing operations.

Lead Edge Capital Makes Growth Investment in Revenue Analytics

October 24, 2022

Cloud & SaaS

Lead Edge Capital has made a strategic growth investment in Revenue Analytics, a cloud-native pricing and revenue management SaaS provider based in Atlanta. The capital will support product innovation, go-to-market expansion, and continued scaling of Revenue Analytics' pricing solutions across travel & hospitality, media, and manufacturing/distribution sectors.

The Riverside Company Invests in Avance Clinical

November 9, 2021

Healthcare Services

The Riverside Company has invested in Avance Clinical, a leading Australian contract research organisation (CRO), to support the company's regional and international expansion. The investment will help Avance accelerate its clinical trials business — including vaccine and gene-technology studies — with a particular focus on growth in North America and Asia.